Product Program year 2023 Source: CMS Open Payments

Foundationone Liquid CDX

Device Oncology

Open in the dashboard

General payments

$248,738

5,957 payments

Research payments

$1,022,950

46 payments

Through program year 2023, $248,738 in general payments and $1,022,950 in research payments were reported against Foundationone Liquid CDX (Oncology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

6 rows
Year Kind Amount Payments
2023 General $130,227 2,719
2023 Research $621,000 5
2022 General $56,647 1,893
2022 Research $178,200 16
2021 General $61,864 1,345
2021 Research $223,750 25

Breakdown

Who paid General payments · program years 2021–2023
  1. Foundation Medicine, Inc. $248,738 5,957 payments
Top recipients General payments · program year 2023
  1. Curtis Chong Medical Oncology · Palo Alto, CA $40,649 31% · 2 payments
  2. Iuliana Shapira Hematology & Oncology · Little Silver, NJ $2,055 2% · 1 payment
  3. Bruna Pellini Ferreira Medical Oncology · Miami, FL $2,055 2% · 1 payment
  4. Deng Zhang Hematology & Oncology · Indianapolis, IN $1,584 1% · 1 payment
  5. Steven Liu Hematology & Oncology · Anchorage, AK $442 <1% · 5 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2023.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2023
  1. Medical Oncology Internal Medicine $50,825 39% · 183 practitioners
  2. Hematology & Oncology Internal Medicine $30,624 24% · 637 practitioners
  3. Nurse Practitioner, Family Nurse Practitioner $8,297 6% · 238 practitioners
  4. Urology $6,965 5% · 214 practitioners
  5. Nurse Practitioner $5,522 4% · 143 practitioners

The top 5 of 65 specialties; each share is of general payments naming this product to practitioners with a specialty in 2023. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2023
  1. California $55,054 42% · 322 recipients
  2. Florida $11,262 9% · 278 recipients
  3. New Jersey $7,972 6% · 101 recipients
  4. Texas $6,129 5% · 131 recipients
  5. New York $6,064 5% · 140 recipients

The top 5 of 50 states; each share is of general payments naming this product in 2023 where a state was reported.

The top 25 states, free in the app

5,957 general · 46 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2023

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record